Aspen Pharma achieves ISO 14001 + OHSAS 18001 Certification
In partnership with our office DQS South Africa, we would like to congratulate Aspen Pharma Australia for achieving certification according ISO 14001:2004 and BS OHSAS 18001:2007 on the 27th June 2016. After a very thorough audit with a team of three DQS auditors over the course of a week, a recommendation for certification was finally achieved. The excellent audit result is a testament to the hard work and dedication exhibited by the Aspen Pharma management team and staff.
Feedback from the DQS audit team confirmed that Aspen has a strong culture and willingness to safeguard their employees and to operate in an environmentally responsible and sustainable way.
About Aspen Pharma
Aspen Australia is one of the largest pharmaceutical companies in Australia, and has one of the most comprehensive portfolios of medicines in the country, covering most disease states. Aspen Pharmacare Australia is a division of Aspen Pharmacare Holdings Limited, the largest listed pharmaceutical company in South Africa. Aspen commenced operations in Australia in May 2001 and since then has acquired many established brands of medicines.
Besides marketing and distributing products owned by the Aspen Group, the company also licenses in products from other companies, and is focused on meeting the needs of their licensors. Aspen Pharma partners and licensors include Merck, CSL, Sanofi-Aventis, GlaxoSmithKline, Novartis, Eli Lilly, Abbot, Teva and others.
More about Aspen: http://www.aspenpharma.com.au/
To contact the DQS offices in Australia and New Zealand, the office in South Africa or any other office of DQS Group, please click here: https://www.dqs-holding.com/en/contact-us/international/